Quick Summary
Capital Life Research holds SEBI Research Analyst registration INH000022163, granted July 28 2025, and is associated with proprietor Rajiv Sharma. Services are delivered via WhatsApp, SMS, and Telegram across equity, futures, options, and commodity segments. The current registration shows a clean complaint record across its nine-month operating history. Half-yearly pricing on premium packages runs up to Rs. 80,000, and combining more than one package can breach SEBI’s Rs. 1,51,000 annual fee cap. Four named users have posted negative reviews or filed complaints on public record. The proprietor also has a separate regulatory history worth reading in full before you subscribe.
Capital Life Research holds a valid, perpetual SEBI Research Analyst registration under INH000022163, effective July 28 2025.
That fact is real and verifiable. But most people searching for this firm are not just checking a registration number.
They want to know what current subscribers are actually saying, whether the pricing adds up, and what to verify before paying.
This page covers all of it: the firm’s services, its complaint data, four specific user complaints, and the pricing structure worth double-checking before you subscribe.
Is Capital Life Research SEBI Registered?
Yes. Capital Life Research holds an active, perpetual SEBI Research Analyst registration (INH000022163), effective July 28 2025.
Verify this yourself at sebi.gov.in under Research Analyst.
Capital Life Research is associated with Rajiv Sharma, whose name appears linked with the firm’s advisory operations.
Before this current registration, he was separately registered with SEBI as an Investment Adviser under INA000001365, operating under the entity name Capital Life Market Research.
That earlier registration predates the current one and carries its own distinct regulatory history.
What Does Capital Life Research Actually Offer?
According to the firm’s own website, recommendations span:
- Equity Cash (NSE and BSE), positional and intraday calls.
- Stock and Index Futures.
- Stock and Index Options, both basic and premium.
- Commodity trading across metals and agri-commodities on MCX and NCDEX.
- BTST and STBT calls.
Services are delivered through WhatsApp, SMS, and Telegram, targeting both new and experienced traders.
The website positions the founder as bringing over a decade of technical analysis expertise, backed by a stated “team of certified market analysts.”
Capital Life Research Owner
Capital Life Research is associated with Rajiv Sharma as proprietor.
Before operating under this brand, he ran Capital Life Market Research as a SEBI-registered Investment Adviser under INA000001365, a category that carries a direct fiduciary duty toward clients.
That earlier registration carries a significant regulatory history, including a formal SEBI order.
A person with this history from a prior, more regulated role, now operating under a new Research Analyst registration, is something every prospective subscriber should read about before paying anything.
The complete regulatory history, including the specific violations SEBI found and the penalty involved, is covered in full on the Rajiv Sharma research analyst page on this site.
Capital Life Market Research Complaints
The website publishes complaint data for the current registration’s reporting periods.
Annual disposal for FY 2025-26 shows zero complaints received, zero resolved, and zero pending, with zero carried forward from any prior year under this specific registration.
What this means in context: INH000022163 is approximately nine months old at the time of writing.
A zero-complaint record over nine months under a new registration is not surprising and is not, by itself, a meaningful indicator either way.
The complaint history that carries real weight belongs to the earlier registration, INA000001365, and is documented in a formal SEBI order.
That history is covered in full on a dedicated page linked further below.
Capital Life Market Research Reviews
These reviews come from publicly visible third-party platforms.
They represent individual opinions and cannot be treated as verified factual conclusions on their own.
1. Allegations of Poor Market Knowledge Leading to Losses
Manish Charan posted a 1-star rating dated July 17 2025, describing the entity as having no knowledge of the stock market and stating that the trade provided resulted in a complete loss.
The review explicitly warned others to stay away.
Yash Lalwani posted a 1-star rating dated May 22, 2025 on the same platform, strongly advising others to avoid the service and describing what he characterised as a complete absence of market knowledge.
2. A Legal Threat Predating the Current Registration
Balvendra Singh, identifying himself as a practising lawyer based in Mumbai, posted a 1-star review dated July 3 2019.
He stated he intended to initiate legal proceedings for cheating and forgery in both Mumbai and Indore, and invited similarly affected investors to contact him.
This review predates the current Research Analyst registration by several years and relates to the period of the earlier Investment Adviser registration.
3. An Undisclosed Fee Complaint From the Earlier Registration
During the period Rajiv Sharma operated as an Investment Adviser under Capital Life Market Research, multiple investors filed formal complaints.
One complaint came from an investor named Suresh, who alleged he was lured in with a small introductory fee and later charged around Rs. 27 lakh in undisclosed service fees.
This complaint relates specifically to the earlier Investment Adviser registration period, not the current Research Analyst registration.
A person with this complaint history from a prior, more regulated role, now operating under a new registration, is something every prospective subscriber should weigh before paying anything.
Capital Life Research Pricing: Does It Breach the SEBI Fee Cap?
The firm’s pricing page lists multiple service categories: Basic Stock Cash, Premium Stock Cash, Basic Stock Future, Premium Stock Future, Index Future, BTST/STBT, Basic Stock Option, Premium Stock Option, Index Option, and Premium Index Option.
Half-yearly prices go up to Rs. 80,000 (base) for Premium Stock Cash, Premium Stock Future, and Premium Stock Option each.
The half-yearly Index Option package is priced at Rs. 65,000 base.
A client subscribing to more than one package simultaneously could easily breach SEBI’s annual fee limit of Rs. 1,51,000 per family.
The pricing page contains no disclosure about this aggregate cap and no guidance on how multi-package subscriptions are managed within the regulatory limit.
Before combining any two packages, calculate your total annual cost and confirm it stays within the SEBI ceiling.
Does the “Proven Performance” Claim Hold Up?
Capital Life Research’s homepage states: “Proven performance in positional, intraday and options segments” and describes “over a decade of technical analysis expertise.”
The website’s FAQ section also states the firm “publishes daily/weekly track records on its website for transparency and client verification.”
No such track record, no systematic record of every recommendation with entries, exits, stop-losses, and outcomes, was visible on any publicly accessible page of the website at the time of writing.
Before subscribing, ask for a direct link to this claimed track record and review it carefully for consistency, losses, and independent verifiability.
Did the service you received not match the “proven performance” claims made before you paid?
Our team reviews your documents and gives an honest evaluation of whether your issue qualifies as a formal regulatory grievance.
Capital Life Market Research vs Capital Life Research: Same Entity, Different Names
If you have seen the entity referred to as Capital Life Market Research in one place and Capital Life Research in another, both names trace back to the same proprietor, Rajiv Sharma.
Capital Life Market Research was the name used under the earlier Investment Adviser registration, INA000001365.
Capital Life Research is the current brand operating under the newer Research Analyst registration, INH000022163.
Some online listings and older reviews still reference the entity as Capitalrise Research Services or simply Capital Research, likely a naming variation or a misremembered brand name from users searching after the fact.
If you encountered any of these names, they most likely point to the same underlying proprietor and business.
This matters practically for one reason: SEBI’s records, complaint disclosures, and enforcement history are indexed by registration number, not by brand name.
Searching only “Capital Life Research” may not surface the older Investment Adviser history, since that operated under a differently named registration.
Always search both INH000022163 and INA000001365 directly on SEBI’s portal to get the complete regulatory picture, regardless of which brand name led you here.
What Should You Verify Before Paying Capital Life Research?
- Verify SEBI registration and regulatory history. Search INH000022163 under Research Analyst, and separately search INA000001365 to review the prior Investment Adviser registration.
- Check claimed track records before paying. Ask for a direct link to the daily or weekly performance data the website claims to publish.
- Get all terms in writing. Request complete fee, refund, and cancellation details before making any payment.
- Confirm total subscription cost limits. If subscribing to multiple packages, confirm the total annual fee does not exceed Rs. 1,51,000.
- Ensure payment goes to the registered entity only. Never transfer money to a personal bank account or unverified UPI ID.
What Ties These Findings Together?
Individually, each observation on this page could be dismissed as a minor issue. Together, they form a pattern worth taking seriously before you subscribe.
A firm with no verifiable performance track record despite claiming to publish one. Pricing that can exceed the SEBI fee cap without any disclosure of that limit.
Four separate named users, across different platforms and different years, describing negative experiences or filing formal complaints. A proprietor whose earlier registration carries a documented regulatory history.
None of these facts alone proves the current service is unsafe to use.
But collectively, they are exactly the kind of pattern that separates a firm worth trusting with genuine due diligence from one that only looks trustworthy on the surface.
Here it is condensed into context-setting paragraphs that link out to each stage instead of repeating the full steps.
Got a Dispute With Capital Life Research? Here Is the Complaint Route
A structured, SEBI-backed escalation path exists if your concern with the firm remains unresolved after direct contact.
The process starts with SEBI SCORES, where you register a formal complaint using registration number INH000022163.
The complete filing guide is on the SEBI SCORES complaint portal page on this site.
If SCORES does not resolve a monetary dispute, SMART ODR offers structured mediation as the next stage. The full process is on the SMART ODR complaint portal page on this site.
For claims that remain unresolved, exchange arbitration delivers a binding decision through the relevant exchange. The process is on the arbitration in stock market page on this site.
For the complete step-by-step walkthrough covering exactly how to file at each stage, the general guide for any Research Analyst complaint is on the complaint against SEBI registered research analyst page on this site.
Conclusion
Capital Life Research holds a genuine, perpetual SEBI Research Analyst registration, and the current registration’s complaint record is clean across nine months of operation.
At the same time, any investor evaluating this entity deserves the full picture: negative user reviews, pricing that can breach the SEBI annual fee cap when packages are combined, an unverifiable “proven performance” claim, and a proprietor whose earlier registration carries formal regulatory history.
None of this prevents Capital Life Research from being a legitimate service going forward. But informed investors ask hard questions before they pay.
Report. Recover. Stay Fraud Free.
Frequently Asked Questions
Yes. Capital Life Research holds SEBI Research Analyst registration INH000022163, effective July 28 2025, on a perpetual basis. Verify current status at sebi.gov.in under Research Analyst.
Rajiv Sharma is the proprietor. He previously held a separate SEBI Investment Adviser registration under INA000001365 as Capital Life Market Research, which carries its own regulatory history.
The current RA registration shows zero complaints across its nine-month operating history. Four named users have posted negative reviews or filed complaints on public record, including one alleging Rs. 27 lakh in undisclosed fees during the earlier Investment Adviser period, and the proprietor's earlier registration is documented in a formal SEBI order.
Yes, potentially. Premium half-yearly packages are priced up to Rs. 80,000 each. Subscribing to more than one package simultaneously can push your total above SEBI's Rs. 1,51,000 annual cap, and the pricing page does not disclose this limit.
The website's FAQ claims daily and weekly track records are published for transparency. No such systematic record was visible on any publicly accessible page at the time of this review. Ask the firm directly for a link before subscribing.
Add us as a preferred source on Google »
